Introduction/background: An improved understanding of cancer-related cachexia and
sarcopenia among patients with hematologic malignancies can improve their health …

Sarcopenia is considered to be a poor prognostic factor for several oncological diseases;
however, some promising results for lymphoma are now available. The definition of …

Simple Summary The effective role of sarcopenia and body changes during treatment in
elderly (> 65 years) Hodgkin lymphoma (HL) is unclear. The aim of our study was to analyze …

2-deoxy-2-[18F]-fluoro-D-glucose (2-[18F] FDG) positron emission tomography/computed
tomography (PET/CT) plays a crucial role in the management of lymphoma in different …

Objective We previously found that the incidence of sarcopenia increased with declining
glucose metabolism of muscle in patients with treatment-naïve diffuse large B-cell lymphoma …

This study investigates the relationship between 18 F-fluorodeoxyglucose ([18 F] FDG)
positron emission tomography/computed tomography (PET/CT) metabolic parameters …

Fluorine-18 fluorodeoxyglucose (FDG) is a glucose analog and the most used PET
radiopharmaceutical. Cellular uptake of FDG is determined by the expression of glucose …

Este estudio investiga la relación entre los parámetros metabólicos de la PET/TC con 18 F-
fludeoxiglucosa ([18 F] FDG), las características clínico-patológicas y la sarcopenia en …

Aim: The aim of this study is to determine whether a novel prognostic score can be obtained
by including low muscle mass in the international prognostic score (IPS) system. Materials & …

Fluorine-18 fluorodeoxyglucose (FDG) is a glucose analog and the most used PET
radiopharmaceutical. Cellular uptake of FDG is determined by the expression of glucose …